|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmaceutics, School of Pharmacy, Hebrew University of Jerusalem, Jerusalem 91120; 2 Department of Cardiology, Hadassah University Hospital, Jerusalem 91120; and 3 Minerva Center and Department of Physics, Bar-Ilan University, Ramat-Gan 52900, Israel
We studied heart rate variability in rats by power scaling spectral analysis (PSSA), autoregressive modeling (AR), and detrended fluctuation analysis (DFA), assessed stability by coefficient of variation between consecutive 6-h epochs, and then compared cross-correlation among techniques. These same parameters were checked from baseline conditions through acute and chronic disease states (streptozotocin-induced diabetes) followed by therapeutic intervention (insulin). Cross-correlation between methods over the entire time period was r = 0.94 (DFA and PSSA), r = 0.81 (DFA and AR), and r = 0.77 (AR and PSSA). Under baseline conditions the scaling parameter measured by DFA and PSSA and the high-frequency (HF) component measured by AR fluctuated around an average value, but these fluctuations were different for the three methods. After diabetes induction, a strong correlation was found between the HF power and the short-term scaling parameter. Despite their differences in methodology, DFA and PSSA assess changes in parasympathetic tone as detected by autoregressive modeling.
heart rate variability; autoregressive modeling; detrended fluctuation analysis; circasemiseptan rhythm; power scaling spectral analysis
This article has been cited by other articles:
![]() |
K. Hu, F. A.J.L. Scheer, R. M. Buijs, and S. A. Shea The circadian pacemaker generates similar circadian rhythms in the fractal structure of heart rate in humans and rats Cardiovasc Res, October 1, 2008; 80(1): 62 - 68. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |